Product Name: Human CXCL9 Antibody (Novimmune patent anti-CXCL9, Research Use)
Catalog Number: NBR-0471
Target Name: CXCL9
Trade Name: Novimmune patent anti-CXCL9
Antibody Drug Description: The drug is a recombinant fully human anti-CXCL9 monoclonal antibody, being developed by Novimmune . Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CXCL9
Synonyms: CMK; crg-10; Humig; MIG; SCYB9
Target Description: Cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response. Chemotactic for activated T-cells. Binds to CXCR3.
Ensembl:  ENSG00000138755
Uniprot:  Q07325